(While navigating through the site, please be sure to disable your pop-up blocker.)
Institute Group Leader - In Vivo Pharmacology and Biology
Education
Required: PhD in one of the natural sciences or related field or Medical degree.
Preferred: PhD, MD or equivalent degree in Biology, Cell Biology, Pharmacology or related field.
Experience
Required: Seven years experience of relevant research experience in laboratory to include three years of supervisory or managerial experience. Successful completion of the LEADing Self Accelerate program may substitute for one year of required supervisory or management experience.
Preferred: 7 years of relevant research and management experience beyond post-doctoral research maintaining hands-on experience.
1. Demonstrate ability to lead teams to drive go/no-go decisions
2. Proficiency and hands-on experience with acute and chronic in vivo models of oncology, immuno-oncology, or autoimmunity
3. Experience with establishing, characterizing, and managing a disease-modeling platform to support therapeutics development
4. Experience in progressing drug programs through early stage preclinical studies through IND submission
5. Ability to model PK/PD using programs such as WinNonLin
6. Excellent project management skills
7. Ability to effectively liaise with CROs and facilitate interactions with academic labs and companies to ensure project progression
8. Self-motivation and flexibility to adapt workplans quickly to changing priorities and deadlines
9. Desire to advance and excel in their position while contributing to overall company growth
It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. http://www.mdanderson.org/about-us/legal-and-policy/legal-statements/eeo-affirmative-action.html